Prospective cost-effectiveness analysis of Cetuximab in metastatic colorectal cancer: evaluation of national cancer institute of Canada clinical trials group CO.17 trial

Nicole Mittmann, Heather-Jane Au, Dongsheng Tu, Christopher O'Callaghan, Pierre Isogai, Christos Karapetis, John Zalcberg, William Evans, Malcolm Moore, Jehan Siddiqui, Brian Findlay, Bruce Colwell, R. Simes, Peter Gibbs, Matthew Links, Niall Tebbutt, Derek Jonker

    Research output: Contribution to journalArticle

    102 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1182-1192
    Number of pages11
    JournalJournal of The National Cancer Institute
    Volume101
    Issue number17
    Publication statusPublished - 2009

    Cite this